participant,SRS2_resp,SRS2_RT,SRS2_item,SRS2_scoring_type,SRS2_treatment_subscale
15,4,8.934,1,positive,mot
15,3,4.45,2,positive,awr
15,1,2.917,3,negative,mot
15,3,2.883,4,positive,rrb
15,4,2.762,5,positive,cog
15,4,1.981,6,positive,mot
15,2,2.403,7,negative,awr
15,2,2.65,8,positive,rrb
15,1,6.028,9,positive,mot
15,4,2.097,10,positive,cog
15,2,1.839,11,negative,mot
15,2,1.508,12,negative,com
15,4,2.529,13,positive,com
15,2,2.09,14,positive,rrb
15,1,2.6,15,negative,cog
15,3,1.505,16,positive,com
15,4,1.997,17,negative,cog
15,4,3.288,18,positive,com
15,2,4.537,19,positive,com
15,4,2.562,20,positive,rrb
15,2,3.612,21,negative,com
15,2,2.523,22,negative,com
15,4,1.95,23,positive,mot
15,4,2.189,24,positive,rrb
15,3,3.882,25,positive,awr
15,3,2.277,26,negative,com
15,4,2.283,27,positive,mot
15,2,2.507,28,positive,rrb
15,2,8.319,29,positive,rrb
15,3,2.088,30,positive,cog
15,3,2.038,31,positive,rrb
15,4,1.221,32,negative,awr
15,3,3.251,33,positive,com
15,2,2.676,34,positive,mot
15,3,3.14,35,positive,com
15,4,1.654,36,positive,com
15,4,1.353,37,positive,com
15,2,2.868,38,negative,com
15,2,3.168,39,positive,rrb
15,4,1.613,40,negative,cog
15,4,2.423,41,positive,com
15,4,2.149,42,positive,cog
15,1,1.422,43,negative,mot
15,1,4.041,44,positive,cog
15,1,3.938,45,negative,awr
15,3,3.347,46,positive,com
15,3,2.058,47,positive,com
15,4,1.814,48,negative,cog
15,2,5.308,49,positive,rrb
15,2,1.484,50,positive,rrb
15,3,2.606,51,positive,com
15,4,1.635,52,positive,awr
15,2,2.318,53,positive,com
15,1,3.181,54,positive,awr
15,1,3.699,55,positive,com
15,2,3.766,56,positive,awr
15,3,1.634,57,positive,com
15,3,2.04,58,positive,cog
15,3,1.582,59,positive,cog
15,3,2.593,60,positive,com
15,3,1.637,61,positive,com
15,4,3.168,62,positive,cog
15,2,2.882,63,positive,rrb
15,4,4.301,64,positive,mot
15,4,1.726,65,positive,mot
